Trabalho de evento-resumo periodico

Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy (2019)

• Authors:
  • Silva, Carolina M P D Carvalho
  • Bittencourt, Márcio Sommer
  • Santos, Marilia
  • Bittar, Cristina
  • Fonseca, Silvia
  • Pinto, Giovanni
  • Costa, Isabela
  • Figueiredo, Clara
  • Siqueira, Julio
  • Bond, Marina
  • Neto, Paulo
  • Gonzalez, Thalita
  • Testa, Laura
  • Hoff, Paulo
  • Kalil-Filho, Roberto
  • Hajjar, Ludhmila
• Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
• Unidade: HU
• DOI: 10.1016/s0735-1097(19)31285-9
• Subjects: NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA ADJUVANTE; PROGNÓSTICO
• Language: Inglês
• Imprenta:
  • Publisher place: New York
  • Date published: 2019
• Source:
  • Título: Journal of the American College of Cardiology
  • ISSN: 0735-1097
  • Volume/Número/Paginação/Ano: v. 73, n. 9, supl. 1, p. 677, mar. 2019
• Conference titles: Annual Scientific Sessions ACC 19: The American College of Cardiology

Informações sobre o DOI: 10.1016/s0735-1097(19)31285-9 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo NÃO é de acesso aberto
  

---

Download do texto completo

Tipo	Nome	Link
	2931490.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SILVA, Carolina M P D Carvalho et al. Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/s0735-1097(19)31285-9. Acesso em: 17 fev. 2026. , 2019

• APA

  Silva, C. M. P. D. C., Bittencourt, M. S., Santos, M., Bittar, C., Fonseca, S., Pinto, G., et al. (2019). Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. doi:10.1016/s0735-1097(19)31285-9

• NLM

  Silva CMPDC, Bittencourt MS, Santos M, Bittar C, Fonseca S, Pinto G, Costa I, Figueiredo C, Siqueira J, Bond M, Neto P, Gonzalez T, Testa L, Hoff P, Kalil-Filho R, Hajjar L. Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy [Internet]. Journal of the American College of Cardiology. 2019 ; 73( 9): 677.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/s0735-1097(19)31285-9

• Vancouver

  Silva CMPDC, Bittencourt MS, Santos M, Bittar C, Fonseca S, Pinto G, Costa I, Figueiredo C, Siqueira J, Bond M, Neto P, Gonzalez T, Testa L, Hoff P, Kalil-Filho R, Hajjar L. Real-life experience of Trastuzumab use among 806 breast cancer patients: role of routine serial echocardiography for the evaluation of asymptomatic ventricular dysfunction in the first 6 months of Trastuzumab therapy [Internet]. Journal of the American College of Cardiology. 2019 ; 73( 9): 677.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/s0735-1097(19)31285-9

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Heart disease and stroke statistics-2019 update: a report From the American Heart Association
• The yield of downstream tests after exercise treadmill testing: a prospective cohort study
• Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
• Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
• Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
• Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
• Impact of coronary remodeling on fractional flow reserve [letter]
• Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
• Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
• Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA